Vildagliptin Recruits Regulatory T Cells in Patients Undergoing Primary Percutaneous Coronary Intervention. [electronic resource]
Producer: 20181109Description: 583-592 p. digitalISSN:- 1532-4311
- Adamantane -- analogs & derivatives
- C-Reactive Protein -- metabolism
- CD4 Lymphocyte Count
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Female
- Humans
- Interferon-gamma -- blood
- Male
- Middle Aged
- Myocardial Infarction -- therapy
- Myocardial Ischemia -- drug therapy
- Nitric Oxide -- blood
- Nitriles -- therapeutic use
- Percutaneous Coronary Intervention -- methods
- Peroxidase -- blood
- Pyrrolidines -- therapeutic use
- Serum Albumin
- T-Lymphocytes, Regulatory -- immunology
- Transforming Growth Factor beta1 -- blood
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.